Invesco Biotechnology & Geno Funds Newsroom

Notable Healthcare Headlines for the Week: Gilead, CVS Health, Sanofi in Focus

Seeking Alpha14:53 ET

Earnings Week Ahead: AMD, PLTR, F, DIS, SHOP, DKNG, AMC, LCID, GOLD, RIVN, and More

Seeking AlphaMay 4 08:00 ET

Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show

Seeking AlphaMay 3 18:10 ET

Gilead and Vertex Pharma Named Among Biotech's Tariff Safe Havens

Seeking AlphaMay 3 14:09 ET

What to Expect From Neurocrine Biosciences's Earnings

BenzingaMay 2 17:03 ET

Liquidia Surges 15% as Court Clears Way for Yutrepia Launch

Seeking AlphaMay 2 14:50 ET

RBC Capital Maintains Outperform on Amgen, Lowers Price Target to $320

BenzingaMay 2 14:32 ET · Ratings

Amgen Analyst Ratings

BenzingaMay 2 14:31 ET · Ratings

Peering Into Natera's Recent Short Interest

BenzingaMay 2 12:00 ET

Amgen Unusual Options Activity For May 02

BenzingaMay 2 11:05 ET

HC Wainwright & Co. Maintains Buy on Biogen, Lowers Price Target to $187

BenzingaMay 2 09:16 ET · Ratings

4 Stocks to Watch on Friday: XOM, CVX, AMGN and TTWO

Seeking AlphaMay 2 09:12 ET

Baird Maintains Outperform on Biogen, Lowers Price Target to $255

BenzingaMay 2 08:26 ET · Ratings

Biogen Analyst Ratings

BenzingaMay 2 08:19 ET · Ratings

Earnings Call Summary | Amgen(AMGN.US) Q1 2025 Earnings Conference

moomoo AIMay 1 20:51 ET · Conference Call

Amgen Beats on Both Lines and Reaffirms Guidance; Stock Flat Post Market

Seeking AlphaMay 1 17:28 ET

Amgen in Charts: XGEVA Sales Reach $566M in Q1

Seeking AlphaMay 1 16:37 ET

Biogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff Impact

BenzingaMay 1 14:46 ET

United Therapeutics Analyst Ratings

BenzingaMay 1 13:38 ET · Ratings

Wall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday?

BenzingaMay 1 13:38 ET